Outcome of the Board meeting dated 30th January, 2026
SICAGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sicagen India's board approved unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31, 2025, along with the auditor's limited review report. On a consolidated basis, Q3 revenue from operations grew strongly by about 26% year-on-year to Rs 26,427 lakhs (vs Rs 20,992 lakhs), while profit before tax and exceptional items more than doubled to Rs 722 lakhs (vs Rs 337 lakhs); net profit rose to Rs 493 lakhs (vs Rs 420 lakhs). On a standalone basis, Q3 revenue rose about 9% to Rs 13,433 lakhs and net profit grew to Rs 393 lakhs (vs Rs 321 lakhs), though nine-month standalone revenue declined roughly 5% to Rs 38,058 lakhs. The company booked a small exceptional charge of Rs 31 lakhs toward the statutory impact of India's new Labour Codes (gratuity and leave remeasurement). Other Comprehensive Income showed a large negative swing of Rs 967 lakhs in Q3 due to fair-value movement in equity instruments, dragging total comprehensive income into negative territory for the quarter.
Consolidated Q3 shows healthy top-line acceleration and a sharp jump in operating profits, which is a positive signal for shareholders, while the standalone core remains weaker with a 9M revenue dip. The Labour Codes exceptional item is small and one-off, and the large negative OCI in equity instruments may cause short-term book-value volatility without affecting cash earnings.